The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study
Clinical trial NCT06851403 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06851403
- Sponsor
- Guangzhou Institute of Respiratory Disease
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-30
- Primary completion
- 2025-12-30
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.